Supply chain & logistics
AI-based monitoring and smart packaging can help to ensure that temperature-sensitive pharmaceuticals maintain efficacy while reducing waste and enhancing compliance.
The pandemic exposed vulnerabilities in global logistics networks, forcing companies to rethink their approach to planning and crisis preparedness. Singh emphasises that being equipped with cutting-edge technology is no longer a luxury but a necessity in ensuring supply chain stability. The ability to quickly identify and address potential disruptions has become a defining factor in maintaining an uninterrupted flow of life-saving medications.
Best practices for ensuring efficacy For companies looking to bolster their supply chain resilience, Brewer advises a multi-pronged approach that integrates technology, governance, and operational efficiency. “Pharmaceutical companies looking to improve supply chain resilience should focus on processes, governance, packaging, and technology that enhance compliance, product integrity, and sustainable operations while simultaneously reducing costs and the time required to manage the supply chain for temperature-sensitive pharmaceutical products.” Real-time tracking, seamless data sharing, and predictive analytics provide a foundation for more responsive logistics networks. Visibility across the entire supply chain ensures that every step, from supplier to end user, is accounted for, reducing the risk of compromised shipments. Singh adds that “fostering collaboration among stakeholders – manufacturers, logistics providers, and regulatory bodies – can help create a more robust and adaptive pharmaceutical supply chain”. Additionally, Brewer emphasises that best practices in transitioning from storage to distribution involve immediate temperature monitoring from the moment a product leaves its storage location, ensuring no period of uncertainty regarding product integrity. “Best practices when transitioning from storage to distribution include immediately monitoring temperature and other characteristics from the moment the product departs from its storage location. This prevents a time period where product integrity is
World Pharmaceutical Frontiers /
www.worldpharmaceuticals.net
unknown.” Establishing clear accountability for each transition phase, along with systematic inventory visibility, reduces errors and enhances compliance. As the demand for temperature-sensitive pharmaceuticals continues to rise, pharmaceutical companies must also consider diversifying supply chain routes to reduce dependency on a single logistics partner. Having alternative routes and backup distribution hubs can be vital in ensuring that disruptions – whether from weather, geopolitical events, or regulatory changes – do not jeopardise product delivery. This is particularly relevant as the pharmaceutical cold chain logistics market is projected to surpass $21bn in value by 2027.
The pharmaceutical industry continues to evolve, and the interplay between technology, sustainability, and regulatory compliance will shape its future. Companies must strike a balance between efficiency and environmental responsibility, with innovations in IoT-enabled smart packaging playing a critical role in reducing waste and optimising supply chain operations. As AI and machine learning become more sophisticated, predictive analytics will provide unprecedented insight into potential risks before they materialise, allowing companies to pre-emptively address challenges rather than react to them.
Ensuring that temperature-sensitive medications reach patients in their intended state demands ongoing investment in innovation and strategic foresight. With AI-powered monitoring, smart packaging solutions, and strengthened supply chain networks, pharmaceutical companies are better equipped than ever to meet these challenges head-on.
As supply chains grow more complex, leveraging real-time data, fostering collaboration, and remaining adaptable in the fact of disruptions will be key to maintaining the integrity of temperature-sensitive pharmaceuticals. The industry is at a turning point where technological advancements and sustainability efforts must go hand in hand to drive efficiency while safeguarding public health. ●
45
SORN340 Studio Images/
www.shutterstock.com
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58
